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1217-52 M&analysis of Antiarrhythmic Drugs for Conversion of 
Atrial Fibrillation and the Maintenance of Sinus Rhythm: 
Combining Efficacy and Adverse Effects 
Leonardo Tamariz, Robert McNamara, Eric Bass, Johns Hopkins University, Baltimore, 
MD 
Background: Atrial fibrillation (AF) is the most common arrhythmia encountered in clim- 
cal practice. The purpose of this analysis is to summarize the evidence on the efficacy 
and adverse effects of agents now available for treatment of atrial fibrillation. Methods: 
MEDLINE and the clinical trial database of the Cochrane Collaboration were searched 
from 1946 to August 2001 for all randomized clinical trials reporting on the efficacy and 
adverse effects of drugs used in the conversion of AF and the maintenance of sinus 
rhythm. We extracted data on study quality, baseline characteristics, conversion of AF, 
maintenance of sinus rhythm and adverse effects. A flxed or random effects model was 
used taking into consideration the heterogeneity of the studies. Results: We identified 36 
randomized clinical trials (RCTs) on conversion of AF and 18 RCTs on maintenance after 
conversion The aggregate odds ratio for conversion of AF, compared to a control treat- 
ment (placebo, digoxin, diltiazem or verapamil) was 30.7 for ibutilide (95% confidence 
interval (Cl) 10.9.86), 12.8 for dofetilide (Cl 5.1-31.8), 13.2 for flecainide (Cl 6.4.27.4), 
3.9 for propafenone (Cl 2.3-6.8), 3.2 for amiodarone (Cl 2.5~5.1), 2.9 for quinidine (Cl 
1.2-6.9) and 1.1 for sotalol (Cl 0.1-6.9). The odds ratio for maintenance of sinus rhythm, 
compared to a control treatment, was 6.5 for amiodarone (Cl 4.1-10.5), 3.0 for pro- 
pafenone (Cl 2.0-4.7), 3.5 for quinidine (Cl 1.4-8.6), 2.5 for sotalol (Cl 1.7.3.7), 4.3 for 
flecainide (Cl 1.3-14.1) and 2.9 for dlsopyramide (Cl 1.4-6.1). The most efficacious drugs 
were associated to the highest risk of adverse effects. For the conversion of AF ibutillde 
and dofetilide had a significant risk of ventricular arrhytmias and for the maintenance of 
sinus rhythm amiodarone had a siginificant risk of adverse effects, however these were 
mostly noncardiac. Conclusion: Strong evidence of efficacy exists for using Ibutilide, 
dofetllide, flecainide, propafenone or amiodarone for conversion of AF, and for using 
amiodarone, propafenone, quinidine or sotalol for maintenance of sinus rhythm. However 
the decision in selecting an antiarrhytmic drug should also be based on the potential risk 
of adverse effects. 
1217-53 The Impact of Implanting Cardioverter-Defibrillators in 
Patients Who Meet the Multicenter Automatic 
Defibrillator Implantation Trial-II Criteria on the Health 
Care System at a Tertiary Referral Center 
Sana M. Al-Khatib, Eric Peterson, James Jollis, Yun Li, Kevin Anstrom. Christopher 
O’Connor, Kerry Lee, Linda Shaw. Robert M. Califf, Duke University Medical Center, 
Durham, NC 
Background: The recently published Multicenter Automatic Defibrillator Implantation 
Trial-II (MADIT-II) showed that patients with history of myocardial infarction and EF of 
30% or less have a significant reduction in mortality when treated with an lmplantable 
cardioverter defibrillator (ICD). The purpose of this study is to determine the impact of 
implanting an ICD in patients who meet the MADIT-II criteria on the health care system at 
a tertiary referral center. 
Methods: We used the Duke Cardiovascular Disease Database that has systematically 
collected the in-hospital clinical experience and the long-term follow-up of all cardiology 
patients who undergo a cardiac catheterization at Duke Medical Center. Of the patients 
who underwent cardiac catheterization between 1986 and 2001, we determined the num- 
ber of patients who would qualify for an ICD based on the MADIT-II results. Extrapolating 
cost data from the Antiarrhythmic Versus Implantable Defibrillators and MADIT-I trials, 
we estimated the cost of ICD implants in these patients. We also estimated the man- 
power needed to implant an ICD in these patients. 
Results: From 1986 through 2001, 51,001 patients underwent at least one cardiac cath- 
eterization. Of these, 1392 (2.7%) met the MADIT-II inclusion criteria. The cost of 
implanting an ICD in these patients would be 44,000,OOO. The cost of Implanting the ICD 
in these patients and managing them over three years would be $141,000,000. At least 
seven full time electrophysiologists would be required to meet the need for additional ICD 
implants within the next year. 
Conclusions: Detailed consideration of our coronary disease population over 15 years 
suggests that the proportion of patients who meet the MADIT-II criteria is relatively small. 
Despite this small number, our data indicate that the implantation of additional ICD’s in 
our institution will have substantial implications regarding manpower and cost. 
1217-54 Clinical Impact of Hand-Carried Cardiac Ultrasound in 
the Medical Clinic Performed by Medical Residents 
Lori B. Croft, Daniel Jacoby, Ira Galin, Thomas McGinn. Martin E. Goldman, Mount Sinai 
Medical Center, New York, NY 
Backaround: Hand-carried cardiac ultrasound (HCU) can provide rapid, bedslde 
assessment of ventricular and valvular function have only been utilized by cardiologists 
or technologists. Proper use of these potential echo-stethoscopes would empower all 
physicians to perform a point of care (POC) brief, diagnosis focused echocardiogram 
(echo) to improve bedside cardiac assessment to complement their physical exam. 
Obiective: To determine (I) whether medical residents with brief echo training can effec- 
tively acquire and interpret HCU POC echo’s and (2) to determine the impact of these 
echo’s on patient (pt) care in their outpatient clinic practice. 
Methods: First and second year medlcal residents underwent a 2 l/2 day hands-on tuto- 
rial to perform and interpret a POC echo using the Phillips Optigo@ (Andover, MA) HES. 
The echo consisted of four views (parasternal long and short, apical four and two cham- 
ber) to define left and right ventricular function and pericardial effusions. Color Doppler 
interrogated for significant valvular abnormalities. No pulsed or continuous wave Doppler 
or M-mode was used. The echo’s were overread and repeated by an echocardtologist 
who evaluated the residents’ technical and interpretive skills. 
Results: Residents performed 53 echo’s in the outpatient clinic as part of their routme pt 
evaluation. The mean time for their echo was 4.32 1.2 minutes. The residents performed 
technically diagnostic echo’s in 94% and interpreted their studies correctly in 89% of pts. 
Residents missed 6 major echo findings. Residents reported their echo reinforced or 
changed their pre-echo diagnosis in 76% of the cases and induced a change in manage- 
ment in 38%. 
Conclusions: This pilot study demonstrated that It IS feasible to train medical residents 
to perform, interpret and integrate a rapid HCU POC echo after a short training period. 
Residents’ echo’s had a sigmficant impact on their pt care. Implications of this study sup- 
port formally educating medical residents to utilize a bedside echo-stethoscope as part of 
their routme pt cars. 
1217-55 Development of a Clinical Quality Care Index Predicts 
Hospital Readmission for Heart Failure 
Ricardo Vicuna, Andrew J. Krainik, Jun Chiong, Stephanie H. Dunla9 University of 
Illinois at Chicago, Chicago, IL 
Background: Despite therapeutic advances in heart failure (HF). readmission rates 
remain high and under use of ACE inhibitors (ACEI) in HF patients (pts) at hospital dls- 
charge is prevalent. Multiple quality care indicators for assessing in-hospital care of HF 
pts. have been published. From the literature, 9 clinical indicators were chosen and com- 
bined into a Quality Care Instrument (QCI) for assessing in-hospital care of HF pts. The 
purpose of this study was to investigate the association between the QCI score and risk 
for HF readmission. 
Methods: All in-pt. medical records from our institution with a pnmary discharge diagno- 
sis of HF occurring during fiscal year 1996 were retrospectively examined and assessed 
for readmiswn through 1998. The 9 clinical indicators were: assessment of LV function; 
ACEI therapy (tx); target ACEI dose; multiple weight measurements; hydralazine-nitrate 
tx if ACEI contraindicated; increased diuretic tx from admiswn; digoxin tx; aspirin tx in 
ischemic pts; sodium/fluid restriction and/or dietary consult. Drug tx was not scored if 
there were contraindications to the drug being evaluated. The overall QCI was calculated 
as [number of indicators present c number of applicable indicators]. Cox proportional 
hazards models were constructed using the QCI as a predictor for readmission, control- 
ling for demographic and clinical variables. 
Results: The study was comprised of 223 pts (53% female, 65% black, 19% Hispanic, 
14% white) with mean age of 60 + 15.3 yrs(SD). QCI scores ranged from O-l, with a 
median of 0.75. 84 pts. (38%) were readmitted at least once during 2 yr. follow-up. Read- 
mission rates at 30, 90, 180, and 365 days were 6%, 15%, 22%, and 30%, respectively. 
Records with a QCI score in the lowest quartile (<0.60), were at highest risk for HF read- 
mission (RR = 2.06, p=O.Ol) and for all other cardiovascular causes (RR=l.66, p=O.O2). 
Conclusion: Use of the Quality Care Instrument was predictive for readmlssion for both 
HF and all cardiovascular causes. The analysis suggests that implementation of the 9 
Indicators in the QCI during HF hospitalizabons may limit future hospitalizations for both 
HF and all cardiovascular causes. 
1217-56 Time Course of Morbidity and Mortality After a 
Myocardial Infarction Complicated by Lefl Ventricular 
Systolic Dysfunction or Heart Failure 
J. G. Cleland, J. Kjekshus, K. Dickstein, S. Om, M. Rome, University of Hull, Kingston 
upon Hull, United Kingdom 
Background: Patients with major left ventricular systolic dysfunction (LVSD) or heart 
failure after a myocardial infarction (Ml) have a poor prognosis, but the time course of 
morbidity and mortality are poorly described in patients receiving contemporary therapy. 
Aims: To describe the time course of stroke, Ml and death in patients who have survived 
an Ml complicated by LVSD or hearl failure. Methods: 5477 patients with MI with evi- 
dence suggesting major cardiac damage were enrolled in the OPTIMAAL trial and fol- 
lowed for a mean of 2.7 years. Events, including death, resuscitated cardiac arrest 
(RCA), MI and stroke, were independently adjudicated. Results: The mean age was 
67.4 years. At study end, 4038 events had been evaluated including 946 deaths, 988 
Ml’s, and 300 strokes. The distribution of events in relation to time from randomization is 
shown in the table. 
Events and (Cumulative % of all Events Adjudicated ) 
Death (N=946) RCA (N=l30) Ml (N=988) Stroke (N=300) 
O-30 days 235 (24.8%) 52 (40.0%) 252 (25.5%) 67 (22.3%) 
30.180 days 202 (46.2%) 28 (61.5%) 270 (52.6%) 34 (33.6%) 
180.365 days 148 (61.8%) 16 (73.8%) 147 (67.7%) 51 (50.6%) 
>365 361 (100%) 34 (100%) 319 (100%) 148 (100%) 
Conclusions: There is a high initial and then a rapid decline in mortality and, to a lesser 
extent, other events after myocardial infarction complicated by LVSD or hearl failure. 
JACC March 19,2002 
Strokes make an important contribution to early and late morbidity in this population. This 
has implications for the design and interpretation of trials in similar populations. Thera- 
peutic targets may change over time. 
1217-57 Rapid Cycle Interventions by Integrated Teams Can 
Effectively Improve Anticoagulation Clinical Care in a 
Safety Net Hospital 
Gene Nakaaawa. Charles R. McKay, William J. French, Debra J. Terrell, Harbor-UCLA, 
Torrance, CA 
Background: Our instltutlon’s medication safety reporting program identified warfarin 
therapy and referral to the Division of Cardiology’s Long-Term Anticoagulation Clinic 
(Clinic) as an opportunity to improve care. Because patient referrals increased and 
stressed limited resources, a Clinical Process improvement program was implemented 
to reduce the percentage of new patients referred to the Clinic who presented with dan- 
gerously elevated INRs (International Normalized Ratio). 
Methods: An integrated Pharmacy, Nursing, Administrator and Physician team par- 
formed a Failure Mode and Effect analysis. Rapid cycle (l-2 months) interventions were 
implemented over a 15-month period to improve specific microsystems of cars (inpatient 
referral services, outpatient clinic services, off-site referrals). A uniform data-collection 
tool and control charts tracked the effectiveness of each intervention. Specific interven- 
tions included adopting simplified outcome metrics, redesigning Clinic patient throughput, 
QA for INR point-of-care testing. limiting dispensed quantities of warfarin, and educating 
patients. residents, physician staff. Cardiac Rehabilitation Service reviewed therapy with 
each referring physician, standard policies were developed for referral to the Clinic and 
for oral vitamin K to treat elevated INRs in the Clinic. 
Results Total Clinic visits increased by 20% during the monitoring period (average of 35 
new patients per month). Average turn-around time from referral to initial visit was 
reduced from 4.9 to 2.2 business days. Percent of new Clinic referrals presenting with 
elevated INRs (>4.0) decreased from 25% (running median 18%) in January 2001 and 
trended down to less than 5% by June 2002. 
Conclusions: Multiple rapid cycle interventions using an integrated team approach 
improved outpatient anticoagulation services and safety. 
1217-58 Contrast-Associated Nephropathy and Clinical 
Outcome of Patients With Chronic Renal Insufficiency 
Undergoing Cardiac Catheterization: Lack of Additive 
Benefit of Acetylcysteine to Saline Hydration 
llan Goldenberg Michael Jonas, Shlomi Matetzki, Michael Shechter, Oren Agranat, 
Yedael Har-Zahav. Dan Elian. Victor Guetta. Heart Institute. Sheba Medical Center. Tel 
Hashomer, Israel 
Background Recently the antioxidant acetylcysteine was shown to attenuate contrast- 
induced nephropathy in patients wth chronic renal insufficiency during computed tomog- 
raphy. However, it has not yet been determlned whether this drug confers a similar bene- 
fit as an adjunct to saltne hydration in patients undergoing coronary angiography. 
Methods The study was deslgned as a double-blind, randomized, placebo-controlled 
trial. Eighty patients with chronic renal insufficiency (serum creatinine 5 1.5 mg per decil- 
iter), who underwent coronary angiography with or without intervention. were randomly 
assigned to receive either acetylcysteine or placebo. Acetylcysteine (600 mg t.i.d.) was 
administered orally for a total of 48 hours, starting 24 hours before the administration of 
the contrast agent. All patients were treated with intravenous sakne (0.45%) at a rate of 1 
ml par kilogram of body weight per hour for 12 hours before and 12 hours after adminis- 
tration of the contrast agent. lopamidol, a nonionic, low-osmolality contrast agent was 
uniformly administered during the procedure. Results The mean (*SD) serum creatinine 
concentration of study participants was 2.0+0.39 mg per deciliter (177*34 pool par liter). 
There was an increase of at least 0.5 mg per deciliter (44 pmol par liter) in the serum cre- 
atinlne concentration 48 hours after cardiac catheterization in 7 of the 80 patients (9%): 
in 4 of the 41 patients (10%) in the acetylcysteine group and in 3 of the 39 patients (8%) 
in the placebo group (p=O.52). Mean serum creatinine was non-significantly reduced 48 
hours after the procedure in the two groups (a decrease of O.OliO.36 mg per deciliter 
[1*32 pmol per liter] vs. 0.03*0.32 mg per deciliter [3t28 vmol per liter] in the acetylcys- 
teine and placebo groups respectively, p=O.77). The incidence of in-hospital adverse 
clinical events and the length of hospital stay did not differ significantly between the two 
treatment groups. Conclusions Our findings do not support routine prophylactic oral 
administration of acetylcysteine as an adjunct to saline hydration for the prevention of 
contrast-induced nephropathy, in patients with chronic renal insufficiency undergoing 
cardiac catheterization. 
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886-l Practice Impact and Patient Acceptance of a 
Cardiologist- Operated Web-Based Billing, Coding, and 
Report Generation System 
Gene E. Myers, Barn Stutler, Eric Griffin, Denise Morris, Rob Ryder, Cardiac and 
Vascular Consultants, Sarasota, FL 
Background The traditional cardiology Practice Management System (PMS), where the 
cardiologist perfons medical services, and their staff does the Billing, Coding, and 
Report Generation (BCRG), has resulted in an increase in full-time employees (FTE) per 
cardiologist, to an all-time high of 4.711 .O. We postulated that the highest accuracyleffi- 
ciency in BCRG would occur if a cardiologist could enter the data at the point and time of 
service (PATS), using a seamlessly upgradeable web-based system. An initial cardiology 
survey showed three obstacles: dislike for typing, lack of computer savvy, and unwilling- 
ness to change existing PMS. 
Methods Using a cardiovascular-specific, internet-based, “out-of-the-box system” and 
desktop and tablet-touch screens, AutoMedicWare’sTM CardioScribe SystemTM was 
interfaced to a common existing PMS. One hundred cardiologist/patient services (hospi- 
tal and office) were monitored to accass the seconds to complete the BCRG at the 
PATS, claims denials and patient response to the transaction. FTE per cardiologist was 
evaluated prior to and after the institution of the system. 
Results: For patients already in the PMS, the BCRG took the cardiologist 50 seconds f 
5 seconds to complete. New patients, added to the system at the PATS by the cardiolo- 
gist took 80 seconds * 5 seconds. Df the 100 claims submitted, 0% ware denied for cod- 
ing errors. With institution of the system, the FTEs per cardiologist could be reduced from 
4.7 to 2.8. Zero percent of patients found the system distracting, 0% intrusive, 57% infor- 
mative, and 0% too time consuming. 52% of patients stated that an insurance carrier had 
denied their claim for physician miscoding and 84% of patients stated that it was impor- 
tant to them for the physician to code correctly the first time. 94% thought the system 
would be helpful to have in other doctors’ offices. 68% of patients expressed concern 
regarding internet patient confidentiality. while 22% had previously heard of HIPAA. 
Conclusion PATS, BCRG by the cardiologist can be accomplished with minimal to no 
intrusion on the cardiologist/patient interaction and is associated with a high degree of 
accuracy and a substantial reduction in the FTE for cardiologists. 
4:15 pm. 
886-2 Patient Acceptance and Satisfaction of Home- 
Telemonitoring in the Management of Heart Failure: 
TEN-HMS Study 
Amala A. Louis Aggie Balk, U. Janssens. Chris Westerteicher, John G. Cleland, 
University of Hull, Hull. United Kingdom, University Hospital, Rotterdam, The 
Netherlands 
Background: Home-telemonitoring of heart rate and rhythm,, blood pressure and weight 
is a promising new strategy for improving the cars of patients with hearl failure. Limited 
information is available on the acceptability of the technology to patients and patient sat- 
isfaction, especially amongst older patients. 
Aims: To describe the acceptability of telemonitoring in patients with heart failure in a 
large randomised study of patients with left ventricular systolic dysfunction (LVSD) and 
chronic heart failure. 
Methods: The Trans-European Network initiative Homecare Management System 
(TEN-HMS) is a randomnad controlled trial comparing usual care (UC), nurse telephone 
contact (NT) and home telemonitoring (TM), in patients with heart failure and LVSD (EF < 
40%) at high risk of readmission. 427 patients were randomized into one of the above 
three groups at a ratio of 1:2:2 respectively. 
Resultr Their mean age was 67~12 years with 31% of patients aged >75 years. 23% 
were women, the mean LV ejection fraction was 25 f 8% and the mean N-terminal pro- 
brain natriuretic peptide level was 715pmolll. On average patients had 2.6 admissions 
accounting for an average of 40 days in hospital in the previous 2 years. Of the 169 
patients randomized to t&monitoring, 7 (4.1%) refused to accept the technology in their 
homes while 5 (2.9%) patients asked for the equipment to be removed and 3 (1.8%) dis- 
continued recording. Overall patient acceptance at 400 days was good at 91.2%. Age did 
not appear an important determinant of acceptance.96% of the patients were well satls- 
fied with the system and 97% found the t&care devices easy to use. 
Conclusions: Home telemonitoring is feasible. Its acceptance amongst patients with 
heart failure is high and it might have an important role in improwg their management. 
